Table 4.
Multivariate Analysis of Prognostic Factors for OS and PFS in 73 LAPC patients
| Factors | OS | PFS | |||||||
|---|---|---|---|---|---|---|---|---|---|
| B Value | Wald Value | P Value | HR (95%CI) | B Value | Wald Value | P Value | HR(95%CI) | ||
| Radiotherapy dose | −0.735 | 8.090 | 0.004 | 0.480(0.289~0.796) | −0.525 | 4.521 | 0.033 | 0.591(0.364~0.960 | |
| Chemotherapy | −0.752 | 6.698 | 0.010 | 0.471(0.267~0.833) | − 0.559 | 4.198 | 0.040 | 0.572(0.335~0.976) | |
| TLG | 0.763 | 8.704 | 0.003 | 2.145(1.292~3.560) | 0.836 | 10.938 | 0.001 | 2.307(1.406~3.787) | |
LAPC locally advanced pancreatic cancer; OS overall survival; PFS progression-free survival; TLG total lesion glycolysis